NEOMED and Biotech Finances are combining their expertise to launch BLOG.NEOMED.CA, a fully audio Ecosysblog® with a mission to cover, in both English and French, news from the players of all scientific, academic, industry, and governmental decision-making centres from within and outside of the NEOMED ecosystem.
Designed as a user-friendly, modern, and proactive platform, BLOG.NEOMED.CA is positioned as the first direct B2B and B2C information outlet in Canada in the field of life sciences. Free to access, BLOG.NEOMED.CA will publish numerous reports on the developments and business strategy choices of life sciences companies, decoding and feedback from major global professional conferences, financial players’ forums, and the activities of scientific, academic, and industry visionaries.
“We are thrilled to solidify the international expansion of our Ecosysblog® concept through BLOG.NEOMED.CA with a high-level centre of excellence like NEOMED,” emphasized Jacques-Bernard Taste, President of Biotech Finances. “I want to thank in particular Max Fehlmann and the entire management team at NEOMED, who committed to this unifying project with conviction and enthusiasm.”
“We are very pleased to launch this new outlet that will generate a dynamic, interactive platform for our life sciences community and serve to feed our thoughts on the challenges that face our industry,” said Max Fehlmann, President and CEO of NEOMED and the NEOMED Institute. “We invite our ecosystem as a whole to join us in animating this blog, stimulating the exchange and sharing of information.”
– 30 –
ABOUT BIOTECH FINANCES
Edited by Editions Européennes de l’innovation, Biotech Finances is the trusted weekly review of life sciences decision makers.
Originally created (1999) by the group Les Echos, Biotech Finances has been an independent magazine since 2005 and is the leader of its field. Biotech Finances covers all economic and financial activities of the innovation ecosystems in France, Belgium, Switzerland, Luxembourg and Quebec, and more broadly, of all the stakeholders and Francophone networks operating from abroad.
Biotech Finances is also a database updated daily since 1999 and with 130,000 pages of archives.
For more information, please visit: www.biotech-finances.com.
ABOUT NEOMED AND THE NEOMED INSTITUTE
NEOMED is a not-for-profit organization whose mission is to foster the development of promising therapeutic approaches emerging from academia and biotechnology companies. NEOMED supports the development of projects up to the stage of human proof of concept. NEOMED is jointly funded by the pharmaceutical industry, the Ministère de l’Économie, de l’Innovation et des Exportations du Québec, and the Networks of Centres of Excellence (NCE) of Canada.
NEOMED operates within the NEOMED Institute, a high-tech research and development centre located at Technoparc Montréal’s Saint-Laurent Campus. NEOMED Institute acts as an open-access drug discovery hub, housing commercial companies and offering a unique environment to nurture collaboration, innovation, and creativity.
For more information, please visit our website: www.neomed.ca.
For more information, please contact:
Mounia Azzi, Ph.D.
Director, Scientific Affairs
Montréal (Québec) H4S 1Z9
President – Editorial Director
Editions Européennes de l’innovation
Biotech Finances / Biotech Transactions
108 rue Bossuet – 69006 LYON
+33 (0)9 80 08 51 45
Download the PDF